Torisel
Term · Oncology and biomedicine · MLC-T-ONC-008767
A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Torisel blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. Torisel is a type of kinase inhibitor. Also called CCI-779 and temsirolimus.
| Identifier | MLC-T-ONC-008767 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CCI-779; temsirolimus |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008767",
"term": "Torisel",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Torisel blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. Torisel is a type of kinase inhibitor. Also called CCI-779 and temsirolimus.",
"synonyms": [
"CCI-779",
"temsirolimus"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/torisel/"
}
Record 16,530 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.